US Stock MarketDetailed Quotes

Kymera Therapeutics (KYMR)

Watchlist
  • 71.120
  • -4.090-5.44%
Close Jan 15 16:00 ET
  • 71.120
  • 0.0000.00%
Post 16:20 ET
5.61BMarket Cap-19.76P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kymera Therapeutics (KYMR) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
-26.12%2.76M
-55.26%11.48M
114.83%22.1M
-40.11%47.07M
-84.56%7.39M
-20.88%3.74M
55.33%25.65M
8.67%10.29M
67.84%78.59M
196.70%47.89M
Operating revenue
-26.12%2.76M
-55.26%11.48M
114.83%22.1M
-40.11%47.07M
-84.56%7.39M
-20.88%3.74M
55.33%25.65M
8.67%10.29M
67.84%78.59M
196.70%47.89M
Cost of revenue
Gross profit
Operating expense
20.52%91.43M
25.41%96.03M
52.75%96.53M
24.44%303.78M
31.18%88.15M
21.90%75.87M
27.85%76.58M
15.33%63.19M
17.32%244.12M
22.69%67.2M
Selling and administrative expenses
12.17%17.34M
1.57%17.65M
13.20%16.27M
15.43%63.53M
14.80%16.33M
9.45%15.46M
22.96%17.37M
14.40%14.37M
25.57%55.04M
22.27%14.23M
-General and administrative expense
12.17%17.34M
1.57%17.65M
13.20%16.27M
15.43%63.53M
14.80%16.33M
9.45%15.46M
22.96%17.37M
14.40%14.37M
25.57%55.04M
22.27%14.23M
Research and development costs
22.65%74.09M
32.41%78.39M
64.39%80.26M
27.06%240.25M
35.58%71.82M
25.55%60.41M
29.36%59.2M
15.61%48.82M
15.12%189.08M
22.81%52.97M
Operating profit
-22.94%-88.67M
-66.04%-84.56M
-40.68%-74.43M
-55.08%-256.71M
-318.16%-80.76M
-25.41%-72.12M
-17.38%-50.93M
-16.72%-52.91M
-2.65%-165.53M
50.01%-19.31M
Net non-operating interest income expense
7.36%10.35M
-10.38%7.94M
-4.63%8.85M
103.45%37.78M
102.33%10M
107.60%9.64M
93.35%8.86M
110.87%9.27M
187.97%18.57M
31.31%4.94M
Non-operating interest income
7.70%10.44M
-9.78%8.05M
-4.56%8.92M
102.65%38.03M
101.40%10.06M
107.07%9.7M
92.66%8.92M
109.81%9.34M
183.27%18.76M
30.65%5M
Non-operating interest expense
63.33%98K
77.05%108K
4.35%72K
27.04%249K
13.46%59K
46.34%60K
27.08%61K
25.45%69K
11.36%196K
-11.86%52K
Other net income (expense)
-3.86M
-4.93M
0
-4.93M
Special income (charges)
---3.86M
--0
--0
---4.93M
--0
--0
--0
---4.93M
--0
--0
-Less:Impairment of capital assets
--3.86M
--0
--0
--4.93M
--0
--0
--0
--4.93M
--0
--0
Income before tax
-31.51%-82.18M
-82.15%-76.61M
-35.06%-65.58M
-52.32%-223.86M
-392.43%-70.75M
-18.20%-62.49M
-8.41%-42.06M
-18.64%-48.56M
5.07%-146.96M
58.79%-14.37M
Income tax
Net income
-31.51%-82.18M
-82.15%-76.61M
-35.06%-65.58M
-52.32%-223.86M
-392.43%-70.75M
-18.20%-62.49M
-8.41%-42.06M
-18.64%-48.56M
5.07%-146.96M
58.79%-14.37M
Net income continuous Operations
-31.51%-82.18M
-82.15%-76.61M
-35.06%-65.58M
-52.32%-223.86M
-392.43%-70.75M
-18.20%-62.49M
-8.41%-42.06M
-18.64%-48.56M
5.07%-146.96M
58.79%-14.37M
Minority interest income
Net income attributable to the parent company
-31.51%-82.18M
-82.15%-76.61M
-35.06%-65.58M
-52.32%-223.86M
-392.43%-70.75M
-18.20%-62.49M
-8.41%-42.06M
-18.64%-48.56M
5.07%-146.96M
58.79%-14.37M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-31.51%-82.18M
-82.15%-76.61M
-35.06%-65.58M
-52.32%-223.86M
-392.43%-70.75M
-18.20%-62.49M
-8.41%-42.06M
-18.64%-48.56M
5.07%-146.96M
58.79%-14.37M
Basic earnings per share
-14.63%-0.94
-63.79%-0.95
-18.84%-0.82
-18.25%-2.98
-252.00%-0.88
8.89%-0.82
13.43%-0.58
1.43%-0.69
12.20%-2.52
58.33%-0.25
Diluted earnings per share
-14.63%-0.94
-63.79%-0.95
-18.84%-0.82
-18.25%-2.98
-252.00%-0.88
8.89%-0.82
13.43%-0.58
1.43%-0.69
12.20%-2.52
58.33%-0.25
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue -26.12%2.76M-55.26%11.48M114.83%22.1M-40.11%47.07M-84.56%7.39M-20.88%3.74M55.33%25.65M8.67%10.29M67.84%78.59M196.70%47.89M
Operating revenue -26.12%2.76M-55.26%11.48M114.83%22.1M-40.11%47.07M-84.56%7.39M-20.88%3.74M55.33%25.65M8.67%10.29M67.84%78.59M196.70%47.89M
Cost of revenue
Gross profit
Operating expense 20.52%91.43M25.41%96.03M52.75%96.53M24.44%303.78M31.18%88.15M21.90%75.87M27.85%76.58M15.33%63.19M17.32%244.12M22.69%67.2M
Selling and administrative expenses 12.17%17.34M1.57%17.65M13.20%16.27M15.43%63.53M14.80%16.33M9.45%15.46M22.96%17.37M14.40%14.37M25.57%55.04M22.27%14.23M
-General and administrative expense 12.17%17.34M1.57%17.65M13.20%16.27M15.43%63.53M14.80%16.33M9.45%15.46M22.96%17.37M14.40%14.37M25.57%55.04M22.27%14.23M
Research and development costs 22.65%74.09M32.41%78.39M64.39%80.26M27.06%240.25M35.58%71.82M25.55%60.41M29.36%59.2M15.61%48.82M15.12%189.08M22.81%52.97M
Operating profit -22.94%-88.67M-66.04%-84.56M-40.68%-74.43M-55.08%-256.71M-318.16%-80.76M-25.41%-72.12M-17.38%-50.93M-16.72%-52.91M-2.65%-165.53M50.01%-19.31M
Net non-operating interest income expense 7.36%10.35M-10.38%7.94M-4.63%8.85M103.45%37.78M102.33%10M107.60%9.64M93.35%8.86M110.87%9.27M187.97%18.57M31.31%4.94M
Non-operating interest income 7.70%10.44M-9.78%8.05M-4.56%8.92M102.65%38.03M101.40%10.06M107.07%9.7M92.66%8.92M109.81%9.34M183.27%18.76M30.65%5M
Non-operating interest expense 63.33%98K77.05%108K4.35%72K27.04%249K13.46%59K46.34%60K27.08%61K25.45%69K11.36%196K-11.86%52K
Other net income (expense) -3.86M-4.93M0-4.93M
Special income (charges) ---3.86M--0--0---4.93M--0--0--0---4.93M--0--0
-Less:Impairment of capital assets --3.86M--0--0--4.93M--0--0--0--4.93M--0--0
Income before tax -31.51%-82.18M-82.15%-76.61M-35.06%-65.58M-52.32%-223.86M-392.43%-70.75M-18.20%-62.49M-8.41%-42.06M-18.64%-48.56M5.07%-146.96M58.79%-14.37M
Income tax
Net income -31.51%-82.18M-82.15%-76.61M-35.06%-65.58M-52.32%-223.86M-392.43%-70.75M-18.20%-62.49M-8.41%-42.06M-18.64%-48.56M5.07%-146.96M58.79%-14.37M
Net income continuous Operations -31.51%-82.18M-82.15%-76.61M-35.06%-65.58M-52.32%-223.86M-392.43%-70.75M-18.20%-62.49M-8.41%-42.06M-18.64%-48.56M5.07%-146.96M58.79%-14.37M
Minority interest income
Net income attributable to the parent company -31.51%-82.18M-82.15%-76.61M-35.06%-65.58M-52.32%-223.86M-392.43%-70.75M-18.20%-62.49M-8.41%-42.06M-18.64%-48.56M5.07%-146.96M58.79%-14.37M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -31.51%-82.18M-82.15%-76.61M-35.06%-65.58M-52.32%-223.86M-392.43%-70.75M-18.20%-62.49M-8.41%-42.06M-18.64%-48.56M5.07%-146.96M58.79%-14.37M
Basic earnings per share -14.63%-0.94-63.79%-0.95-18.84%-0.82-18.25%-2.98-252.00%-0.888.89%-0.8213.43%-0.581.43%-0.6912.20%-2.5258.33%-0.25
Diluted earnings per share -14.63%-0.94-63.79%-0.95-18.84%-0.82-18.25%-2.98-252.00%-0.888.89%-0.8213.43%-0.581.43%-0.6912.20%-2.5258.33%-0.25
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -